Clinical Trial Update: IVIG - West Nile Encephalitis: Safety and Efficacy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the safety and efficacy of intravenous immunoglobulin (IVIG) for West Nile virus–associated encephalitis. The study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• West Nile Encephalitis
• West Nile Virus Infection

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: West Nile Virus | Phase 1, Phase 2 | Status: COMPLETED